| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 5,710,000 | | Cost of Revenue | 2,590,000 | | | Gross Profit | 3,120,000 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 2,079,000 | | Non Recurring | 1,096,000 | | Others | 113,000 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | (168,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 50,000 | | Earnings Before Interest And Taxes | (118,000) | | Interest Expense | 257,000 | | Income Before Tax | (375,000) | | Income Tax Expense | (61,000) | | Minority Interest |
-
| | | | Net Income From Continuing Ops | (312,000) | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (312,000) | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | ($312,000) |
|
0.29% Nasdaq 
0.29 (1.06%) 
Income Statement
